Results 321 to 330 of about 572,501 (357)
Some of the next articles are maybe not open access.
Current Opinion in Urology, 2010
To review recent developments in imaging for bladder cancer (BCa) diagnosis and staging.Recent technical advances in multidetector computed tomography (CT) and, especially, CT urography make CT the preferred imaging modality for diagnosis and staging of BCa.
Nigel C, Cowan, Jeremy P, Crew
openaire +2 more sources
To review recent developments in imaging for bladder cancer (BCa) diagnosis and staging.Recent technical advances in multidetector computed tomography (CT) and, especially, CT urography make CT the preferred imaging modality for diagnosis and staging of BCa.
Nigel C, Cowan, Jeremy P, Crew
openaire +2 more sources
Journal of Urology, 1982
A randomized controlled prospective evaluation of intravesical and percutaneous bacillus Calmette-Guerin immunotherapy was done in 57 patients with transitional cell carcinoma of the bladder. In addition, 9 patients at high risk for tumor recurrence were treated with bacillus Calmette-Guerin produced a self-limited cystitis and 1 complication ...
D L, Lamm +3 more
openaire +2 more sources
A randomized controlled prospective evaluation of intravesical and percutaneous bacillus Calmette-Guerin immunotherapy was done in 57 patients with transitional cell carcinoma of the bladder. In addition, 9 patients at high risk for tumor recurrence were treated with bacillus Calmette-Guerin produced a self-limited cystitis and 1 complication ...
D L, Lamm +3 more
openaire +2 more sources
Hematology/Oncology Clinics of North America, 1992
The majority of patients with bladder cancer have superficial disease. Occupational exposure to metabolites of aniline dyes and other aromatic amines has been associated with the development of bladder cancer. Latency periods can reach 50 years. Cigarette smoking has also been strongly linked to bladder cancer as an etiologic factor.
K A, Itoku, B S, Stein
openaire +2 more sources
The majority of patients with bladder cancer have superficial disease. Occupational exposure to metabolites of aniline dyes and other aromatic amines has been associated with the development of bladder cancer. Latency periods can reach 50 years. Cigarette smoking has also been strongly linked to bladder cancer as an etiologic factor.
K A, Itoku, B S, Stein
openaire +2 more sources
Preventive Medicine, 1976
Abstract 4-Aminobiphenyl, 2-naphthylamine, benzidine, 1-naphthylamine and 4-nitrobiphenyl are responsible for occupational bladder cancer in man. Bladder tumors are found in workers who make or use these substances and possibly in those who purify them. The manufacture of auramine and magenta is also associated with the disease.
openaire +2 more sources
Abstract 4-Aminobiphenyl, 2-naphthylamine, benzidine, 1-naphthylamine and 4-nitrobiphenyl are responsible for occupational bladder cancer in man. Bladder tumors are found in workers who make or use these substances and possibly in those who purify them. The manufacture of auramine and magenta is also associated with the disease.
openaire +2 more sources
Postgraduate Medicine, 1992
Although the incidence of bladder cancer has not changed in the last 40 years, treatment has greatly decreased morbidity. Invasive disease, however, remains fatal. Bladder cancer is not common in the general population, and current laboratory tests of urine are not adequate for screening the population at large.
openaire +2 more sources
Although the incidence of bladder cancer has not changed in the last 40 years, treatment has greatly decreased morbidity. Invasive disease, however, remains fatal. Bladder cancer is not common in the general population, and current laboratory tests of urine are not adequate for screening the population at large.
openaire +2 more sources
Clinical Radiology, 1992
Bladder cancer is the most common of the malignant urothelial turnouts, accounting for approximately 6% of all male and 2% of all female cancers. These tumours usually present in later life, the majority of patients presenting between the ages of 60 and 70 years.
openaire +2 more sources
Bladder cancer is the most common of the malignant urothelial turnouts, accounting for approximately 6% of all male and 2% of all female cancers. These tumours usually present in later life, the majority of patients presenting between the ages of 60 and 70 years.
openaire +2 more sources
Current Urology Reports, 2018
Bladder cancer (BC) is the second most common genitourinary malignancy, with a growing population of survivors globally. Over the past two decades, there has been a growing awareness of not only the oncologic, but also the quality of life ramifications of a BC diagnosis, treatment, and surveillance. In the current review, the literature surrounding the
openaire +2 more sources
Bladder cancer (BC) is the second most common genitourinary malignancy, with a growing population of survivors globally. Over the past two decades, there has been a growing awareness of not only the oncologic, but also the quality of life ramifications of a BC diagnosis, treatment, and surveillance. In the current review, the literature surrounding the
openaire +2 more sources
Nursing
Abstract: Bladder cancer, the 10th most common cancer globally, primarily manifests as urothelial cell carcinoma. Risk factors involve acquired genetic mutations and congenital predispositions, impacting diagnosis and management. This article discusses the risk factors, clinical presentation, and treatment strategies, with emphasis on ...
openaire +2 more sources
Abstract: Bladder cancer, the 10th most common cancer globally, primarily manifests as urothelial cell carcinoma. Risk factors involve acquired genetic mutations and congenital predispositions, impacting diagnosis and management. This article discusses the risk factors, clinical presentation, and treatment strategies, with emphasis on ...
openaire +2 more sources